Investor Watch
Featured #1
Longeveron: potential to be a stem-cell Powerhouse
HLHS (Hypoplastic Left Heart Syndrome), Alzheimer's, PDCM (Pediatric Dilated Cardiomyopathy), aging-related frailty (7/2/26)
Click a tier above to see the explanation.
May 2026
Investor Presentation →